TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| P | %ret | 1 | 1 | 2 | 4 | 10 | -3 | -23 | -48 | 0 | -12 |
| P | %wins | 100 | 100 | 0 | 0 | 0 | 40 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/2/23 16:27 | 3/1/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sigal Charles Elliott | CA | D | P | 57 | 22.73 | 0 | 3 | 14 | 20 | I | |||||||||||||||
1/9/23 11:51 | 1/5/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sigal Charles Elliott | CA | D | P | 62 | 24.96 | 0 | 3 | 17 | 17 | I | |||||||||||||||
1/5/23 17:00 | 1/3/23 | VIR | Vir Biotechnology, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Sigal Charles Elliott | CA | D | P.m | 127 | 25.43 | 0 | 5 | 51 | 15 | I | |||||||||||||||
5/19/16 16:47 | 5/19/16 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Sigal Charles Elliott | NJ | D | P | 23 | 1.56 | 1 | 15 | 4 | 367 | I | -42 | -2 | 13 | -7 | -1 | -2 | 11 | 6 | 8 | -5 | -25 | -50 | |||
5/18/16 19:34 | 5/16/16 | ADAP | Adaptimmune Therapeutics Plc | X0 | Health | BioPrd | Biological Products, (No Diag | Sigal Charles Elliott | NJ | D | P.m | 69 | 1.53 | 1 | 45 | 15 | 352 | I | -46 | -17 | 6 | -5 | -4 | 4 | 10 | 2 | 12 | -1 | -21 | -46 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |